BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES

Phase 1MediChip™Positive

AI Analysis

Summary

BioSapien announces partnerships with Roswell Park and BA Sciences as US manufacturing partners ahead of Phase I clinical trials for MediChip, its localized cancer drug delivery platform.

Clinical Trial Data

Phase

Phase I

Importance:5/10

Sentiment:

0.60

manufacturing partnershipPhase 1oncologydrug deliverylocalized therapy

Related Companies

$WHEN

Read the original article

Published by PR Newswire Biotech on July 1, 2026 2:00 PM

Read Original